HHS Relaxes Proposed Common Rule Restrictions on Biospecimen Research

HHS backed down from implementing its more controversial provisions in a broad overhaul of its Common Rule, including requiring researchers to obtain written consent before testing a donor’s biospecimens, even if the samples were presented with no personally identifying information.
Source: Drug Industry Daily